which glp 1 agonists have cardiovascular benefit GLP-1 Receptor in Heart Failure The Many Cardiovascular Benefits of

These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers

& Zhang, S

2018;8:726 elik Tekeli M, Yaln Y, Verdi H, Akta Y, elebi N

doi: 10.1016/j.ejphar.2017.07.015 [DOI] [PubMed] [Google Scholar] 31

Therefore, initial studies could be designed to explore whether and how GLP-1R agonists alter GABAergic and dopaminergic pathways in the brain

Tissues were washed in PBS and incubated for 2 h with fluorescent secondary antibody Alexa Fluor 594 donkey anti-rabbit (1:500, Jackson ImmunoResearch, USA)